A detailed history of Huntleigh Advisors, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Huntleigh Advisors, Inc. holds 2,445 shares of JNJ stock, worth $469,146. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,445
Previous 2,473 1.13%
Holding current value
$469,146
Previous $410 Million 8.93%
% of portfolio
0.07%
Previous 0.1%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 29, 2025

SELL
$146.36 - $159.82 $4,098 - $4,474
-28 Reduced 1.13%
2,445 $374 Million
Q1 2025

Apr 29, 2025

BUY
$142.06 - $167.7 $4,972 - $5,869
35 Added 1.44%
2,473 $410 Million
Q4 2024

Apr 29, 2025

BUY
$143.34 - $165.86 $349,462 - $404,366
2,438 New
2,438 $353 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $502B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Huntleigh Advisors, Inc. Portfolio

Follow Huntleigh Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntleigh Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Huntleigh Advisors, Inc. with notifications on news.